Latest AI and machine learning research in allergy & immunology for healthcare professionals.
BACKGROUND: Traditional auscultation, heavily dependent on the subjective judgment of physicians, ca...
BACKGROUND: The prognosis for patients with glioblastoma (GBM) remains extremely poor, a challenge l...
Increased sensory nerve density has been described in type II inflammatory conditions and is linked ...
Oncolytic peptides (OPs) represent a promising class of cancer therapeutics capable of rapidly lysin...
BACKGROUND: Testing for Blood-Borne-Viruses (BBVs) such as the human immunodeficiency virus (HIV), h...
Monoclonal proteins (M-proteins) serve as critical biomarkers for plasma cell dyscrasias, yet their ...
BACKGROUND: Ovarian cancer (OC) is a highly aggressive malignancy with poor prognosis and limited re...
BACKGROUND: Lung squamous cell carcinoma (LUSC) exhibits poor prognosis and a highly complex tumor i...
BACKGROUND: Viral encephalitis (VE) is an acute inflammatory disease caused by viral infection. Chil...
Respiratory diseases, including bronchial asthma (BA), chronic obstructive pulmonary disease (COPD),...
RNA-based cancer immunotherapy has emerged as a next-generation strategy in oncology, harnessing the...
Lower-grade glioma (LGG) is a highly heterogeneous disease, making accurate prognosis prediction and...
Food allergy is a big concern in food safety. Thermal processing is an effective approach to tackle ...
OBJECTIVE: Disulfidptosis is a recently discovered mechanism of cell death caused by disulfide stres...
Pancreatic ductal adenocarcinoma remains one of the deadliest malignancies, characterized by late di...
The 2022 global outbreak of clade IIb mpox represented a turning point in public health's handling o...
The interplay between mitochondria and programmed cell deaths (PCD) is associated with tumor pathoge...
Triaptosis, an emerging form of cell death, remains poorly characterized in terms of its heterogenei...
Accurate identification of causative allergens is critical for personalized management of allergic r...
This invited commentary grew out of a presentation made at the 2025 ConRad Meeting in Munich, German...
Multicellular programs in the tumour microenvironment (TME) drive cancer pathogenesis and response t...